Target Price | $77.52 |
Price | $73.00 |
Potential | 6.19% |
Number of Estimates | 36 |
36 Analysts have issued a price target Nike 2026 . The average Nike target price is $77.52. This is 6.19% higher than the current stock price. The highest price target is $126.00 72.60% , the lowest is $38.38 47.42% . | |
A rating was issued by 43 analysts: 21 Analysts recommend Nike to buy, 20 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Nike stock has an average upside potential 2026 of 6.19% . Most analysts recommend the Nike stock at Purchase. |
38 Analysts have issued a sales forecast Nike 2026 . The average Nike sales estimate is $46.3b . This is 0.01% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $49.5b 6.83% , the lowest is $43.7b 5.62% .
This results in the following potential growth metrics:
2025 | $46.3b | 9.84% |
---|---|---|
2026 | $46.3b | 0.01% |
2027 | $48.7b | 5.26% |
2028 | $51.2b | 5.12% |
2029 | $54.5b | 6.33% |
2030 | $57.5b | 5.54% |
2031 | $61.0b | 6.10% |
2032 | $64.6b | 5.79% |
32 Analysts have issued an Nike EBITDA forecast 2026. The average Nike EBITDA estimate is $3.7b . This is 17.96% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.6b 1.44% , the lowest is $2.9b 36.43% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $4.5b | 40.14% |
---|---|---|
2026 | $3.7b | 17.96% |
2027 | $4.9b | 32.38% |
2028 | $6.1b | 25.03% |
2029 | $7.8b | 27.07% |
2030 | $8.6b | 10.72% |
2031 | $10.4b | 20.14% |
2032 | $11.3b | 9.43% |
2025 | 9.74% | 33.61% |
---|---|---|
2026 | 7.99% | 17.96% |
2027 | 10.05% | 25.78% |
2028 | 11.95% | 18.91% |
2029 | 14.28% | 19.50% |
2030 | 14.98% | 4.90% |
2031 | 16.96% | 13.22% |
2032 | 17.55% | 3.48% |
38 Nike Analysts have issued a net profit forecast 2026. The average Nike net profit estimate is $2.5b . This is 23.05% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.4b 5.92% , the lowest is $1.9b 42.03% .
This results in the following potential growth metrics and future Net Margins:
2025 | $3.2b | 43.53% |
---|---|---|
2026 | $2.5b | 23.05% |
2027 | $3.6b | 46.82% |
2028 | $4.4b | 22.13% |
2029 | $5.6b | 26.54% |
2030 | $6.8b | 20.82% |
2031 | $8.4b | 23.82% |
2032 | $9.4b | 11.35% |
2025 | 6.95% | 37.36% |
---|---|---|
2026 | 5.35% | 23.03% |
2027 | 7.46% | 39.44% |
2028 | 8.67% | 16.22% |
2029 | 10.31% | 18.92% |
2030 | 11.81% | 14.55% |
2031 | 13.78% | 16.68% |
2032 | 14.50% | 5.22% |
38 Analysts have issued a Nike forecast for earnings per share. The average Nike EPS is $1.68 . This is 22.22% lower than earnings per share in the financial year 2025. The highest EPS forecast is $2.31 6.94% , the lowest is $1.26 41.67% .
This results in the following potential growth metrics and future valuations:
2025 | $2.16 | 42.09% |
---|---|---|
2026 | $1.68 | 22.22% |
2027 | $2.46 | 46.43% |
2028 | $3.01 | 22.36% |
2029 | $3.81 | 26.58% |
2030 | $4.60 | 20.73% |
2031 | $5.70 | 23.91% |
2032 | $6.34 | 11.23% |
Current | 33.80 | 47.54% |
---|---|---|
2026 | 43.50 | 28.71% |
2027 | 29.63 | 31.89% |
2028 | 24.26 | 18.12% |
2029 | 19.17 | 20.98% |
2030 | 15.87 | 17.21% |
2031 | 12.82 | 19.22% |
2032 | 11.51 | 10.22% |
Based on analysts' sales estimates for 2026, the Nike stock is valued at an EV/Sales of 2.30 and an P/S ratio of 2.33 .
This results in the following potential growth metrics and future valuations:
Current | 2.30 | 3.77% |
---|---|---|
2026 | 2.30 | 0.10% |
2027 | 2.19 | 4.99% |
2028 | 2.08 | 4.88% |
2029 | 1.96 | 5.95% |
2030 | 1.85 | 5.25% |
2031 | 1.75 | 5.75% |
2032 | 1.65 | 5.47% |
Current | 2.33 | 3.69% |
---|---|---|
2026 | 2.33 | 0.01% |
2027 | 2.21 | 4.99% |
2028 | 2.10 | 4.87% |
2029 | 1.98 | 5.96% |
2030 | 1.87 | 5.25% |
2031 | 1.77 | 5.76% |
2032 | 1.67 | 5.47% |
Analyst | Rating | Action | Date |
---|---|---|---|
TD Cowen |
Hold
➜
Buy
|
Upgrade | Sep 10 2025 |
JP Morgan |
Neutral
➜
Overweight
|
Upgrade | Jul 28 2025 |
Argus Research |
Hold
➜
Buy
|
Upgrade | Jul 01 2025 |
Baird |
Outperform
➜
Outperform
|
Unchanged | Jun 27 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | Jun 27 2025 |
B of A Securities |
Buy
➜
Buy
|
Unchanged | Jun 27 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jun 27 2025 |
Analyst Rating | Date |
---|---|
Upgrade
TD Cowen:
Hold
➜
Buy
|
Sep 10 2025 |
Upgrade
JP Morgan:
Neutral
➜
Overweight
|
Jul 28 2025 |
Upgrade
Argus Research:
Hold
➜
Buy
|
Jul 01 2025 |
Unchanged
Baird:
Outperform
➜
Outperform
|
Jun 27 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Jun 27 2025 |
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jun 27 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jun 27 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.